Seeking Alpha

Jazz Pharmaceuticals (JAZZ -0.4%) says regulators have given final approval to a generic version...

Jazz Pharmaceuticals (JAZZ -0.4%) says regulators have given final approval to a generic version of the company's Luvox CR anti-depressant by Par Pharmaceutical. Additionally, Kohlberg Kravis Roberts (KKR) confirnms that it sold around 3.73M shares late last week at $58.28 each for $218.5M in gross proceeds, reducing its stake to around 6.5%.
Comments (1)
  • What % of Jazz sales does Luvox represent
    14 Mar 2013, 02:43 PM Reply Like
DJIA (DIA) S&P 500 (SPY)